About Matthew Disney
Form D filings for Ribonaut Therapeutics in 2023 list Matthew Disney as executive officer and director.
Matthew Disney first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Disney in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Disney works with at each company, as listed on that company's latest Form D.
Ribonaut Therapeutics, Inc. · Form D, Jan 4, 2023
ZC
Zachary Collins
Executive officer
ST
Steven Tregay
Director
LL
Lusong Luo
Director
JD
Jessica Childs-Disney
Promoter